Patient characteristics | Total (n = 423) | Men (n = 319) | Women (n = 104) | p-value |
Age (years) | 63 ± 13.1 | 60.9 ± 12.7 | 69.2 ± 12.4 | <0.001 |
Current smokers | 201 (47.9%) | 173 (54.4%) | 28 (27.5%) | <0.001 |
Former smokers (>1 year) | 100 (23.8%) | 92 (28.9%) | 8 (7.8%) | <0.001 |
Hypertension | 235 (55.5%) | 165 (51.7%) | 70 (67.3%) | <0.001 |
Dyslipidemia | 0.062 | |||
Drug treatment No drug treatment | 134 (32.5%) 73 (17.7%) | 94 (30.3%) 62 (20%) | 40 (39.2%) 11 (10.8%) | |
Diabetes mellitus | 112 (26%) | 76 (24%) | 36 (35%) | 0.107 |
Family historya | 39 (11%) | 29 (10.5%) | 10 (12.3%) | 0.800 |
Previous ischemic heart disease | 44 (10.4%) | 35 (11%) | 9 (8.7%) | 0.626 |
Chronic kidney disease | 14 (3.4%) | 7 (2.3%) | 7 (6.9%) | 0.052 |
Anemia | 33 (8.2%) | 19 (6.3%) | 14 (14.1%) | 0.023 |
AMI data | ||||
Systolic blood pressure at admission (mmHg) | 130 [114–150] | 130 [112–148] | 140 [120–164] | 0.003 |
Infarct location | 0.713 | |||
Anterior | 151 (35.7%) | 112 (35.1%) | 39 (37.5%) | |
Inferior | 231 (54.6%) | 178 (55.8%) | 53 (51%) | |
Killip class | 0.137 | |||
I | 341 (83.2%) | 264 (84.9%) | 77 (77.8%) | |
II | 35 (8.1%) | 22 (7.1%) | 11 (11.1%) | |
III | 16 (3.9%) | 9 (2.9%) | 7 (7.1%) | |
IV | 21 (4.9%) | 16 (5.1%) | 4 (4.1%) | |
LVEF | 52.1 ± 12 | 52,5 ± 12 | 51 ± 12 | 0.283 |
Blood test at admission | Total (n = 423) | Men (n = 319) | Women (n = 104) | p-value |
Hb (gr/dL) | 14 ± 1.8 | 14.4 ± 1.7 | 12.9 ± 1.7 | <0.001 |
GFR (mL/min/m2) | 60 [60–60] | 60 [60–60] | 60 [60–60] | 0.006 |
Basal glucose (mg/dL) | 111 [98–136] | 110 [98–133] | 114 [97–148] | 0.423 |
HbA1c (%) (in DM) | 7.25 [6.60–8.53] | 7.30 [6.60–8.53] | 7.10 [6.60–8.08] | 0.643 |
Total Cholesterol (mg/dL) | 183 [150–214] | 182 [151–212] | 188 [150–219] | 0.425 |
LDL-Cholesterol (mg/dL) | 112 [84–139] | 112 [85–138] | 112 [82–142] | 0.842 |
HDL-Cholesterol (mg/dL) | 44 [37–53] | 42 [36–50] | 49 [41–60] | <0.001 |
Triglycerides (mg/dL) | 120 [88–168] | 124 [91–173] | 112 [80–159] | 0.061 |